Privacy
Privacy Policy - EMD Serono, Inc. ("EMD Serono")
General
EMD Serono respects the privacy of every individual who visits www.mslifelines.com (the "Web Site"). This Privacy Policy outlines the information EMD Serono will collect and how we will use that information.
Personally-Identifiable Information
There may be cases where EMD Serono will ask you for personally-identifiable information such as your name, mailing address, and email address. EMD Serono will not collect any personally-identifiable information about you unless you provide it to us voluntarily.
Except as stated in this Privacy Policy, or as EMD Serono may be legally required, or as otherwise stated at the time personally-identifiable information is gathered, we will not provide personally-identifiable information to third parties who are not under the direction and control of EMD Serono.
Children
The Web Site is not directed at individuals under thirteen years of age, and EMD Serono does not intend to collect any personally-identifiable information from such individuals, unless otherwise stated at the time such information is collected.
Information Collected Automatically
EMD Serono may also automatically collect non-personally-identifiable information about your use of the Web Site, such as the domain from which you access the Internet (for example, aol.com, if you are connecting from an America Online account), the date and time you access the Web Site, and the Internet address of the website from which you linked directly to our Web Site. This information will not be linked to personally-identifiable information. EMD Serono may use this information to analyze and enhance the Web Site, and may aggregate this information and share such aggregated information with business partners, sponsors and other third parties.
Links to Other Web Sites
The Web Site may allow links to various other web sites. EMD Serono assumes no responsibility for the information practices of sites you are able to access through the Web Site. These links to other sites do not imply affiliation or endorsement of a linked site.
Security
The importance of security for all personally-identifiable information associated with visitors to the Web Site is of utmost concern to us. Unfortunately, no data transmission over the Internet can be guaranteed to be secure. As a result, EMD Serono cannot ensure or warrant the security of any information you transmit to us, and you do so at your own risk. Once we receive your personally-identifiable information, we will take reasonable efforts to ensure its security on our systems.
Your Acceptance of These Terms
By using the Web Site, you signify your assent to the EMD Serono Privacy Policy. If you do not agree to this Policy, please do not use the Web Site. Your continued use of the Web Site following the posting of changes to these terms will mean you accept those changes. EMD Serono will, however, use personally-identifiable information only in accordance with the version of the Privacy Policy under which the information was collected.
Terms and Conditions of Use
Use of the Web Site is governed by the EMD Serono Legal Statement.
Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of Rebif® (interferon beta-1a) in the US 
Prescribing Information - Medication Guide
This information is intended only for residents of the United States.
Indication
Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence
of some of the physical disability that is common in people with MS. Rebif is not approved for treatment of
chronic progressive MS. Rebif is available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration
pack by prescription only.
Important Safety Information
Before beginning treatment, patients should discuss with their doctor the potential benefits and risks
associated with Rebif. Let your doctor know if you have a history of depression, seizures, liver disease,
thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions
to medications. Tell your doctor about all medicines you take, including prescription and non-prescription
medicines, vitamins, and herbal supplements. Rebif and other medicines may affect each other causing serious
side effects. Talk to your doctor before you take any new medicines. Rebif is not recommended for women who
are or plan to become pregnant.
Potential serious side effects of Rebif include depression and risk of suicide, liver problems, risk to
pregnancy, injection-site problems, and severe allergic reactions. Allergic reactions are rare and may be
associated with difficulty in breathing and loss of consciousness, which require immediate medical attention.
The most common side effects with Rebif are injection-site reactions, flu-like symptoms (fever, chills, muscle
aches, tiredness), depression, abdominal pain, increased liver enzymes, and blood cell count decreases. Let
your doctor know if you have any of these symptoms or feel sad, tired, hot or cold, or experience hives,
rashes, bruising, yellowing of the skin, or a change in body weight (gain or loss).
Compared with Avonex, side effects were generally similar despite the higher, more frequent dosing of Rebif.
Differences included people taking Avonex had more flulike symptoms than those taking Rebif. People taking
Rebif had a greater number of injection-site reactions, elevated liver enzymes, and decreased white blood cell
counts; these events also occurred more frequently with Rebif posttransition versus prior use of Avonex.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch,
or call 1-800-FDA-1088.
This information is not intended to replace discussions with your doctor. For additional information about
Rebif, please consult the Prescribing Information and Medication Guide and talk to your doctor.
You can also visit www.mslifelines.com or call toll-free 1-877-44-REBIF (1-877-447-3243). Rebif is available
by prescription only.
MS LifeLines is an educational support service for people living with MS and their families. MS LifeLines and
MS LifeLines Ambassadors are sponsored by EMD Serono, Inc. and Pfizer Inc.
Rebif, Rebiject II and MS LifeLines are registered trademarks and the Rebif logo is a trademark of EMD Serono,
Inc. or its affiliates.
MS in Balance Your Life in Full is a service mark of EMD Serono, Inc. or its affiliates.
Copyright 2010 EMD Serono, Inc. All rights reserved.